Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Cytori Therapeutics Inc. (CYTX) unveiled a pact to commercialize the company's cell therapies for the cardiovascular, renal and diabetes markets in Australia and several Asian nations. Shares of Cytori soared 46% to $3.05 after hours, after the company said partner Lorem Vascular will pay up to $500 million in fees for a 30-year exclusive license to Cytori. http://bigcharts.marketwatch.com/quickchart/quickchart.asp?s...
Print the post Back To Top
No. of Recommendations: 0
WOW! CYTX hasn't seen 3 bucks since last year. Pretty impressive run.

Calabogie
Print the post Back To Top
No. of Recommendations: 0
An interesting ticker, CYTX, broke out today.

Happy New Year!
Print the post Back To Top
No. of Recommendations: 1
0Now that it's back to its support, it may get interesting again.

~aj
Print the post Back To Top
Advertisement